Dyne Therapeutics Inc (DYN)
23.99
-0.31
(-1.28%)
USD |
NASDAQ |
Dec 20, 16:00
25.18
+1.19
(+4.96%)
After-Hours: 20:00
Dyne Therapeutics Shareholders Equity (Quarterly): 705.54M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 15.63B |
| Regenxbio Inc | 301.42M |
| Avidity Biosciences Inc | 1.503B |
| Catalyst Pharmaceuticals Inc | 660.94M |
| Sarepta Therapeutics Inc | 1.221B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 768.84M |
| Total Liabilities (Quarterly) | 63.30M |